Erika Serrano Del Pozo

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 2

Top Topics

Randomized Controlled Trial

Magnetic Resonance

Induced Pluripotent Stem Cells

Top Venues

Science translational medicine

Genes & development

This page only lists publications with an associated author ORCID identifier.

Publications

Mariano F Zacarias-Fluck, Daniel Massó-Vallés, Fabio Giuntini, Íñigo González-Larreategui, Jastrinjan Kaur, Sílvia Casacuberta-Serra, Toni Jauset, Sandra Martínez-Martín, Génesis Martín-Fernández, Erika Serrano Del Pozo, Laia Foradada, Judit Grueso, Lara Nonell, Marie-Eve Beaulieu, Jonathan R Whitfield, Laura Soucek
Reducing MYC's transcriptional footprint unveils a good prognostic gene signature in melanoma. Genes & development (2023)
Marie-Eve Beaulieu, Toni Jauset, Daniel Massó-Vallés, Sandra Martínez-Martín, Peter Rahl, Loïka Maltais, Mariano F Zacarias-Fluck, Sílvia Casacuberta-Serra, Erika Serrano Del Pozo, Christopher Fiore, Laia Foradada, Virginia Castillo Cano, Meritxell Sánchez-Hervás, Matthew Guenther, Eduardo Romero Sanz, Marta Oteo, Cynthia Tremblay, Génesis Martín, Danny Letourneau, Martin Montagne, Miguel Ángel Morcillo Alonso, Jonathan R Whitfield, Pierre Lavigne, Laura Soucek
Intrinsic cell-penetrating activity propels Omomyc from proof of concept to viable anti-MYC therapy. Science translational medicine 11 (484) (2020)